This is a Validated Antibody Database (VAD) review about human ROR1, based on 4 published articles (read how Labome selects the articles), using ROR1 antibody in all methods. It is aimed to help Labome visitors find the most suited ROR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ROR1 synonym: NTRKR1; dJ537F10.1
Knockout validation
Cell Signaling Technology domestic rabbit polyclonal |
| Cell Signaling Technology ROR1 antibody (Cell Signaling, 4102) was used in western blot knockout validation on mouse samples at 1:100 (fig 4a) and in western blot on human samples at 1:100 (fig 5d, s8a). Cancer Sci (2021) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (60-D) |
| Santa Cruz Biotechnology ROR1 antibody (Santa, sc-130386) was used in western blot on human samples (fig s4). Cells (2019) ncbi |
Abcam
domestic goat polyclonal |
| In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Abcam ROR1 antibody (Abcam, ab111174) was used in immunocytochemistry on human samples at 1:200 (fig 3b). Nat Commun (2016) ncbi |
Cell Signaling Technology
domestic rabbit polyclonal |
| Cell Signaling Technology ROR1 antibody (Cell Signaling, 4102) was used in western blot knockout validation on mouse samples at 1:100 (fig 4a) and in western blot on human samples at 1:100 (fig 5d, s8a). Cancer Sci (2021) ncbi |
domestic rabbit polyclonal |
| Cell Signaling Technology ROR1 antibody (Cell Signaling, 4102) was used in western blot on human samples (fig 2). Clin Exp Metastasis (2016) ncbi |
domestic rabbit polyclonal |
| In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Cell Signaling Technology ROR1 antibody (Cell Signalling, 4102) was used in western blot on human samples at 1:50 (fig 1b). Nat Commun (2016) ncbi |
Articles Reviewed
- Bleckmann A, Conradi L, Menck K, Schmick N, Schubert A, Rietkötter E, et al. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis. 2016;33:309-23 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments